Role of SPECT/CT in detection of the marked metastatic lymph node and the sentinel node, after neoadjuvant chemotherapy in patients with breast cancer

Role of SPECT/CT in detection of the marked metastatic lymph node and the sentinel node, after neoadjuvant chemotherapy in patients with breast cancer

Bibliographic Details
Main Authors:	E. Dilege, O. Falay, O. Agcaoglu, N. Kapucuoglu
Format:	Article
Language:	English
Published:	Elsevier 2021-04-01
Series:	Breast
Online Access:	http://www.sciencedirect.com/science/article/pii/S0960977621002381

Similar Items

P204 SPECT/CT lymphoscintigraphy can accurately localize the sentinel lymph nodes and the clipped node in breast cancer patients undergoing targeted axillary dissection after neoadjuvant chemotherapy
by: E. Dilege, et al.
Published: (2023-03-01)

Omitting axillary lymph node dissection in breast cancer patients with metastatic sentinel node after neoadjuvant chemotherapy
by: B. Kuru, et al.
Published: (2021-04-01)

SPECT/CT in Localization of Sentinel Lymph Node of Skin Tumors
by: ZHU Shikun, et al.
Published: (2023-07-01)

Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer
by: Khadidja Brahmi, et al.
Published: (2017-06-01)

An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumors
by: Teele Kuusk, et al.
Published: (2018-12-01)

Secretory breast carcinoma with metastatic sentinel lymph node
by: Graceffa Giuseppa, et al.
Published: (2006-12-01)

Ultrasound Accuracy in Detection of Metastatic Axillary Lymph Nodes in Breast Cancer after Neoadjuvant Chemotherapy
by: Majid Akrami, et al.
Published: (2023-01-01)

Sentinel lymph node biopsy and neoadjuvant chemotherapy in the management of early breast cancer: Safety considerations and timing
by: Jenny Edge, et al.
Published: (2017-06-01)

Our house believes that: The clipped lymph node is the true sentinel node after neoadjuvant chemotherapy in N+ patients
by: Benigno Acea-Nebril, et al.
Published: (2023-12-01)

Feasibility and accuracy of sentinel lymph node biopsy in clinically node-positive breast cancer after neoadjuvant chemotherapy: a meta-analysis.
by: Jian-Fei Fu, et al.
Published: (2014-01-01)

Non-sentinel lymph node metastasis prediction in breast cancer with metastatic sentinel lymph node: impact of molecular subtypes classification.
by: Fabien Reyal, et al.
Published: (2012-01-01)

Superparamagnetic Iron Oxide for Identifying Sentinel Lymph Node in Breast Cancer after Neoadjuvant Chemotherapy: Feasibility Study
by: Andrzej Kurylcio, et al.
Published: (2021-07-01)

Prognostic implications of regression of metastatic axillary lymph nodes after neoadjuvant chemotherapy in patients with breast cancer
by: Yul Ri Chung, et al.
Published: (2021-06-01)

Study on intraoperative localization of sentinel lymph nodes using freehand SPECT in breast cancer patients
by: Maria-Ioanna Argentou, et al.
Published: (2022-05-01)

Is number of sentinel nodes enougth after neoadjuvant chemotherapy?
by: S. Aragón, et al.
Published: (2021-04-01)

Predictors of non-sentinel lymph node metastasis in clinical early stage (cT1-2N0) breast cancer patients with 1-2 metastatic sentinel lymph nodes
by: Azmi Lale, et al.
Published: (2020-04-01)

The Oncologic Safety of Sentinel Lymph Node Biopsy in Patients with Node-Positive Breast Cancer with Complete Response to Neoadjuvant Chemotherapy: A Single-Center Experience
by: Ismail Can Tercan, et al.
Published: (2023-01-01)

Intraoperative imprint cytology versus histological diagnosis for the detection of sentinel lymph nodes in breast cancer treated with neoadjuvant chemotherapy
by: Ronald Enrique Delgado-Bocanegra, et al.
Published: (2018-08-01)

Comparison of the Ultrasound Visibility of Tissue Markers in Metastatic Lymph Nodes after Neoadjuvant Chemotherapy in Patients with Breast Cancer
by: Ka Eun Kim, et al.
Published: (2022-10-01)

Sentinel Lymph Node Biopsy in Breast Cancer: Predictors of Axillary and Non-Sentinel Lymph Node Involvement
by: Hakan Postacı, et al.
Published: (2013-12-01)

Preoperative SPECT/CT + intraoperative CT fusion enabling surgical augmented reality to target sentinel lymph node in endometrial cancer
by: Lise Lecointre, et al.
Published: (2022-11-01)

Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancer
by: Andreis, D, et al.
Published: (2016)

Novel Biomarkers Aim at Detecting Metastatic Sentinel Lymph Nodes in Breast Cancer
by: Behnaz Bakaeean, et al.
Published: (2020-05-01)

Regional Recurrence Rates With or Without Complete Axillary Dissection for Breast Cancer Patients with Node-Positive Disease on Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy
by: Diane C. Ling, MD, et al.
Published: (2020-03-01)

The Feasibility and Accuracy of Sentinel Lymph Node Biopsy in Initially Clinically Node-Negative Breast Cancer after Neoadjuvant Chemotherapy: A Systematic Review and Meta-Analysis.
by: Chong Geng, et al.
Published: (2016-01-01)

Sentinel Lymph Node Biopsy Following Neoadjuvant Chemotherapy: Review of the Literature and Recommendations for Use in Patient Management
by: Yan Xing, et al.
Published: (2004-10-01)

Risk factors of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph nodes
by: HOU Xiaosa, YANG Zhenjiang
Published: (2021-06-01)

The role of sentinel lymph nodes in breast cancer
by: R. Nikitenko, et al.
Published: (2022-06-01)

Sentinel lymph node biopsy in breast cancer
by: Volkan Genç, et al.
Published: (2008-01-01)

Sentinel lymph node biopsy in breast neoplasms
by: Višnjić Milan, et al.
Published: (2009-01-01)

Magnetometer-Guided Sentinel Lymph Node Dissection in Prostate Cancer: Rate of Lymph Node Involvement Compared with Radioisotope Marking
by: Svenja Engels, et al.
Published: (2021-11-01)

“Sentinel lymph node imaging with sequential SPECT/CT lymphoscintigraphy before and after neoadjuvant chemoradiotherapy in patients with cancer of the oesophagus or gastro-oesophageal junction – a pilot study”
by: Stefan Gabrielson, et al.
Published: (2018-12-01)

Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinel nodes after neoadjuvant therapy (ADARNAT trial)
by: Amparo Garcia-Tejedor, et al.
Published: (2023-08-01)

Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer with axillary node metastasis: A survey of clinical practice
by: Sae Byul Lee, et al.
Published: (2019-01-01)

Axillary lymph node dissection could be omitted in the breast cancer patients with a limited sentinel lymph node involvement following neoadjuvant systemic treatment
by: Ana Car-Peterko, et al.
Published: (2021-01-01)

Non-sentinel node metastasis prediction during surgery in breast cancer patients with one to three positive sentinel node(s) following neoadjuvant chemotherapy
by: Jung Whan Chun, et al.
Published: (2023-03-01)

Factors Associated with Axillary Lymph Node Status in Clinically Node-Negative Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
by: Chi-Chang Yu, et al.
Published: (2022-09-01)

The Accuracy of Sentinel Lymph Node Biopsy Compared with Axillary Lymph Node Dissection in Breast Cancer
by: Abdolrasul Talei, et al.
Published: (2011-10-01)

Non-visualization of axillary pathological lymph nodes in breast cancer patients on SPECT/CT and during operation
by: Shenghua Zhu, et al.
Published: (2024-03-01)

Prognosis according to clinical and pathologic lymph node status in breast cancer patients who underwent sentinel lymph node biopsy alone after neoadjuvant therapy.
by: Sae Byul Lee, et al.
Published: (2021-01-01)